HI HB1096 | 2023 | Regular Session
Note: Carry Foward to future HB1096
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 25 2023 - 25% progression, died in committee
Action: 2023-01-30 - Referred to HLT, JHA, referral sheet 3
Pending: House Health Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 25 2023 - 25% progression, died in committee
Action: 2023-01-30 - Referred to HLT, JHA, referral sheet 3
Pending: House Health Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Amends section 329-40, Hawaii Revised Statutes, to require the medical director of a methadone treatment program to conduct a medical evaluation that offers testing for Hepatitis C exposure and infection. Requires that a methadone treatment program have policies and procedures in place for screening and referrals to care and curative treatment.
Title
Relating To Methadone Treatment Programs.
Sponsors
| Rep. Scott Saiki [D] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-01-30 | House | Referred to HLT, JHA, referral sheet 3 |
| 2023-01-25 | House | Introduced and Pass First Reading. |
| 2023-01-23 | House | Pending introduction. |
Same As/Similar To
HB1096 (Carry Over) 2023-01-30 - Referred to HLT, JHA, referral sheet 3
SB1394 (Same As) 2023-01-30 - Referred to HHS, CPN.
SB1394 (Same As) 2023-01-30 - Referred to HHS, CPN.
Subjects
Hawaii State Sources
| Type | Source |
|---|---|
| Summary | https://www.capitol.hawaii.gov/session/measure_indiv.aspx?billtype=HB&billnumber=1096&year=2023 |
| Text | https://www.capitol.hawaii.gov/sessions/session2023/bills/HB1096_.HTM |
